世界のマウスモデル市場2021年ｰ2028年：製品タイプ別（トランスジェニックマウスモデル、ハイブリッド/コンジェニックマウスモデル、ノックアウトマウスモデル、発癌物質誘発性＆自発性マウスモデル、非近交系マウスモデル、近交系マウスモデル、移植マウスモデル、条件付け/外科的改変マウスモデル）、専門別、サービス別

• 英文タイトル：Mice Model Market (Product Type: Transgenic Mice Model, Hybrid/Congenic Mice Model, Knockout Mice Model, Carcinogen-induced & Spontaneous Mice Model, Outbred Mice Model, Inbred Mice Model, Transplantation Mice Model, and Conditioned/Surgically Modified Mice Model; Specialty: Immunology, Central Nervous System [CNS], Oncology, Cardiovascular, Diabetes, and Metabolism & Regulation; and Service: Breeding & Rederivation Services, Cryopreservation & Cryorecovery Services, Quarantine Services, Genetic Testing Services, Model In-licensing Services, In Vivo & In Vitro Pharmacology Services, Genetically Engineered Model Services, and Other Services [Surgical and Line Rescue]) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

• レポートコード：MRC2205A015 • 出版社/出版日：Transparency Market Research / 2022年3月8日 • レポート形態：英文、PDF、191ページ • 納品方法：Eメール • 産業分類：バイオ

• 販売価格（消費税別）

Single User	￥857,660 (USD5,795)	▷ お問い合わせ
Multi User	￥1,301,660 (USD8,795)	▷ お問い合わせ
Corporate License	￥1,745,660 (USD11,795)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

Transparency Market Research社の本調査レポートは、世界のマウスモデル市場について調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、種類別（トランスジェニックマウスモデル、ハイブリッド/コンジェニックマウスモデル、ノックアウトマウスモデル、発癌物質誘発性＆自発性マウスモデル、移植マウスモデル）分析、専門別分析、サービス別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などの項目を掲載しています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・世界のマウスモデル市場規模：種類別（トランスジェニックマウスモデル、ハイブリッド/コンジェニックマウスモデル、ノックアウトマウスモデル、発癌物質誘発性＆自発性マウスモデル、移植マウスモデル） ・世界のマウスモデル市場規模：専門別 ・世界のマウスモデル市場規模：サービス別 ・世界のマウスモデル市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況

Mice Model Market – Scope of Report

TMR’s report on the global mice model market studies past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global mice model market for the period 2017–2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global mice model market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global mice model market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global mice model market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global mice model market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global mice model market.

The report delves into the competitive landscape of the global mice model market. Key players operating in the global mice model market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global mice model market that have been profiled in this report.

Key Questions Answered in Mice Model Market Report
What is the scope of growth of product companies in the global mice model market?
What will be the Y-o-Y growth of the global mice model market between 2019 and 2028?
What is the influence of changing trends in technologies on the global mice model market?
Will North America be the most profitable market for mice model providers?
Which factors are anticipated to hamper the growth of the global mice model market during the forecast period?
Which are the leading companies in the global mice model market?

Research Methodology
A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global mice model market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global mice model market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the mice model market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the mice model market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global mice model market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global mice model market more reliably and accurately.

レポート目次

---

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Mice Model Market
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Mice Model Market Analysis and Forecast, 2017–2028
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Industry Developments
5.2. Overview of Mice Model Market
5.3. Technological Advancements
5.4. COVID-19 Pandemics Impact on Industry (value chain and short / mid / long term impact)
6. Global Mice Model Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Type, 2017–2028
6.3.1. Transgenic Mice Model
6.3.2. Hybrid/Congenic Mice Model
6.3.3. Knockout Mice Model
6.3.4. Carcinogen-induced & Spontaneous Mice Model
6.3.5. Outbred Mice Model
6.3.6. Inbred Mice Model
6.3.7. Transplantation Mice Model
6.3.8. Conditioned/Surgically Modified Mice Model
6.4. Market Attractiveness Analysis, by Type
7. Global Mice Model Market Analysis and Forecast, by Specialty
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Specialty, 2017–2028
7.3.1. Immunology
7.3.2. Central Nervous System (CNS)
7.3.3. Oncology
7.3.4. Cardiovascular
7.3.5. Diabetes
7.3.6. Metabolism & Regulation
7.4. Market Attractiveness Analysis, by Specialty
8. Global Mice Model Market Analysis and Forecast, by Services
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Services, 2017–2028
8.3.1. Breeding & Rederivation Services
8.3.2. Cryopreservation & Cryorecovery Services
8.3.3. Quarantine Services
8.3.4. Genetic Testing Services
8.3.5. Model In-licensing Services
8.3.6. In Vivo & In Vitro Pharmacology Services
8.3.7. Genetically Engineered Model Services
8.3.8. Other Services (surgical and line rescue)
8.4. Market Attractiveness Analysis, by Services
9. Global Mice Model Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Country/Region
10. North America Mice Model Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Type, 2017–2028
10.2.1. Transgenic Mice Model
10.2.2. Hybrid/Congenic Mice Model
10.2.3. Knockout Mice Model
10.2.4. Carcinogen-induced & Spontaneous Mice Model
10.2.5. Outbred Mice Model
10.2.6. Inbred Mice Model
10.2.7. Transplantation Mice Model
10.2.8. Conditioned/Surgically Modified Mice Model
10.3. Market Value Forecast, by Specialty, 2017–2028
10.3.1. Immunology
10.3.2. Central Nervous System (CNS)
10.3.3. Oncology
10.3.4. Cardiovascular
10.3.5. Diabetes
10.3.6. Metabolism & Regulation
10.4. Market Value Forecast, by Services, 2017–2028
10.4.1. Breeding & Rederivation Services
10.4.2. Cryopreservation & Cryorecovery Services
10.4.3. Quarantine Services
10.4.4. Genetic Testing Services
10.4.5. Model In-licensing Services
10.4.6. In Vivo & In Vitro Pharmacology Services
10.4.7. Genetically Engineered Model Services
10.4.8. Other Services (surgical and line rescue)
10.5. Market Value Forecast, by Country, 2017–2028
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Type
10.6.2. By Specialty
10.6.3. By Services
10.6.4. By Country
11. Europe Mice Model Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2017–2028
11.2.1. Transgenic Mice Model
11.2.2. Hybrid/Congenic Mice Model
11.2.3. Knockout Mice Model
11.2.4. Carcinogen-induced & Spontaneous Mice Model
11.2.5. Outbred Mice Model
11.2.6. Inbred Mice Model
11.2.7. Transplantation Mice Model
11.2.8. Conditioned/Surgically Modified Mice Model
11.3. Market Value Forecast, by Specialty, 2017–2028
11.3.1. Immunology
11.3.2. Central Nervous System (CNS)
11.3.3. Oncology
11.3.4. Cardiovascular
11.3.5. Diabetes
11.3.6. Metabolism & Regulation
11.4. Market Value Forecast, by Services, 2017–2028
11.4.1. Breeding & Rederivation Services
11.4.2. Cryopreservation & Cryorecovery Services
11.4.3. Quarantine Services
11.4.4. Genetic Testing Services
11.4.5. Model In-licensing Services
11.4.6. In Vivo & In Vitro Pharmacology Services
11.4.7. Genetically Engineered Model Services
11.4.8. Other Services (surgical and line rescue)
11.5. Market Value Forecast, by Country/Sub-region, 2017–2028
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Type
11.6.2. By Specialty
11.6.3. By Services
11.6.4. By Country/Sub-region
12. Asia Pacific Mice Model Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2017–2028
12.2.1. Transgenic Mice Model
12.2.2. Hybrid/Congenic Mice Model
12.2.3. Knockout Mice Model
12.2.4. Carcinogen-induced & Spontaneous Mice Model
12.2.5. Outbred Mice Model
12.2.6. Inbred Mice Model
12.2.7. Transplantation Mice Model
12.2.8. Conditioned/Surgically Modified Mice Model
12.3. Market Value Forecast, by Specialty, 2017–2028
12.3.1. Immunology
12.3.2. Central Nervous System (CNS)
12.3.3. Oncology
12.3.4. Cardiovascular
12.3.5. Diabetes
12.3.6. Metabolism & Regulation
12.4. Market Value Forecast, by Services, 2017–2028
12.4.1. Breeding & Rederivation Services
12.4.2. Cryopreservation & Cryorecovery Services
12.4.3. Quarantine Services
12.4.4. Genetic Testing Services
12.4.5. Model In-licensing Services
12.4.6. In Vivo & In Vitro Pharmacology Services
12.4.7. Genetically Engineered Model Services
12.4.8. Other Services (surgical and line rescue)
12.5. Market Value Forecast, by Country/Sub-region, 2017–2028
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Type
12.6.2. By Specialty
12.6.3. By Services
12.6.4. By Country/Sub-region
13. Latin America Mice Model Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type , 2017–2028
13.2.1. Transgenic Mice Model
13.2.2. Hybrid/Congenic Mice Model
13.2.3. Knockout Mice Model
13.2.4. Carcinogen-induced & Spontaneous Mice Model
13.2.5. Outbred Mice Model
13.2.6. Inbred Mice Model
13.2.7. Transplantation Mice Model
13.2.8. Conditioned/Surgically Modified Mice Model
13.3. Market Value Forecast, by Specialty, 2017–2028
13.3.1. Immunology
13.3.2. Central Nervous System (CNS)
13.3.3. Oncology
13.3.4. Cardiovascular
13.3.5. Diabetes
13.3.6. Metabolism & Regulation
13.4. Market Value Forecast, by Services, 2017–2028
13.4.1. Breeding & Rederivation Services
13.4.2. Cryopreservation & Cryorecovery Services
13.4.3. Quarantine Services
13.4.4. Genetic Testing Services
13.4.5. Model In-licensing Services
13.4.6. In Vivo & In Vitro Pharmacology Services
13.4.7. Genetically Engineered Model Services
13.4.8. Other Services (surgical and line rescue)
13.5. Market Value Forecast, by Country/Sub-region, 2017–2028
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Type
13.6.2. By Specialty
13.6.3. By Services
13.6.4. By Country/Sub-region
14. Middle East & Africa Mice Model Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2017–2028
14.2.1. Transgenic Mice Model
14.2.2. Hybrid/Congenic Mice Model
14.2.3. Knockout Mice Model
14.2.4. Carcinogen-induced & Spontaneous Mice Model
14.2.5. Outbred Mice Model
14.2.6. Inbred Mice Model
14.2.7. Transplantation Mice Model
14.2.8. Conditioned/Surgically Modified Mice Model
14.3. Market Value Forecast, by Specialty, 2017–2028
14.3.1. Immunology
14.3.2. Central Nervous System (CNS)
14.3.3. Oncology
14.3.4. Cardiovascular
14.3.5. Diabetes
14.3.6. Metabolism & Regulation
14.4. Market Value Forecast, by Services, 2017–2028
14.4.1. Breeding & Rederivation Services
14.4.2. Cryopreservation & Cryorecovery Services
14.4.3. Quarantine Services
14.4.4. Genetic Testing Services
14.4.5. Model In-licensing Services
14.4.6. In Vivo & In Vitro Pharmacology Services
14.4.7. Genetically Engineered Model Services
14.4.8. Other Services (surgical and line rescue)
14.5. Market Value Forecast, by Country, 2017–2028
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Type
14.6.2. By Specialty
14.6.3. By Services
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Company Profiles
15.2.1. Charles River Laboratories International, Inc.
15.2.1.1. Company Overview
15.2.1.2. Financial Overview
15.2.1.3. Product Portfolio
15.2.1.4. Business Strategies
15.2.1.5. Recent Developments
15.2.2. Crescendo Biologics Limited
15.2.2.1. Company Overview
15.2.2.2. Financial Overview
15.2.2.3. Product Portfolio
15.2.2.4. Business Strategies
15.2.2.5. Recent Developments
15.2.3. Deltagen, Inc.
15.2.3.1. Company Overview
15.2.3.2. Financial Overview
15.2.3.3. Product Portfolio
15.2.3.4. Business Strategies
15.2.3.5. Recent Developments
15.2.4. genOway S.A.
15.2.4.1. Company Overview
15.2.4.2. Financial Overview
15.2.4.3. Product Portfolio
15.2.4.4. Business Strategies
15.2.4.5. Recent Developments
15.2.5. Harbour Antibodies BV
15.2.5.1. Company Overview
15.2.5.2. Financial Overview
15.2.5.3. Product Portfolio
15.2.5.4. Business Strategies
15.2.5.5. Recent Developments
15.2.6. Harlan Laboratories, Inc.
15.2.6.1. Company Overview
15.2.6.2. Financial Overview
15.2.6.3. Product Portfolio
15.2.6.4. Business Strategies
15.2.6.5. Recent Developments
15.2.7. ImmunoGenes AG
15.2.7.1. Company Overview
15.2.7.2. Financial Overview
15.2.7.3. Product Portfolio
15.2.7.4. Business Strategies
15.2.7.5. Recent Developments
15.2.8. The Jackson Laboratory
15.2.8.1. Company Overview
15.2.8.2. Financial Overview
15.2.8.3. Product Portfolio
15.2.8.4. Business Strategies
15.2.8.5. Recent Developments
15.2.9. Taconic Biosciences, Inc.
15.2.9.1. Company Overview
15.2.9.2. Financial Overview
15.2.9.3. Product Portfolio
15.2.9.4. Business Strategies
15.2.9.5. Recent Developments
15.2.10. TransGenic, Inc.
15.2.10.1. Company Overview
15.2.10.2. Financial Overview
15.2.10.3. Product Portfolio
15.2.10.4. Business Strategies
15.2.10.5. Recent Developments

---